The initial public offering (IPO) of GPT Healthcare, a prominent hospitals chain and healthcare services provider, concluded on February 26 with an impressive response from investors. The IPO was heavily oversubscribed during the bidding period from February 22 to February 26.
With the IPO allotment finalized, all attention is now on the listing of GPT Healthcare IPO, scheduled for February 29, Thursday.
Grey Market Premium (GMP) analysis indicates a positive sentiment towards GPT Healthcare shares. The GMP today stood at ₹17 per share, suggesting an estimated listing price of ₹203 apiece, representing a premium of 9.14% over the issue price of ₹186 per share.
Subscription status reveals strong investor interest, with the IPO oversubscribed 8.52 times overall. The retail category saw 2.44 times subscription, while Qualified Institutional Buyers (QIBs) and Non-Institutional Investors (NIIs) subscribed 17.30 times and 11.02 times, respectively.
GPT Healthcare raised ₹525.14 crore from the IPO, consisting of a fresh issue of 22 lakh equity shares worth ₹40 crore and an offer for sale (OFS) of 2.61 crore shares worth ₹485.14 crore. The IPO was offered at a price band of ₹177 to ₹186 per share.
JM Financial Limited served as the book running lead manager for the IPO, with Link Intime India Private Ltd acting as the IPO registrar. The shares are set to list on both BSE and NSE.
